Evidence map›Paper›PMID 42350499›Full record

ArticleScientific reports2026

Enhanced urine refractive index sensing using a defect-engineered one-dimensional photonic crystal.

Arafa H Aly

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Arafa H AlyTH-PPM Group, Physics Department, Faculty of Science, Beni-Suef University, Beni Suef, 62111, Egypt. arafaaly@aucegypt.edu.ORCID https://orcid.org/0000-0003-0795-378X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, a defect-engineered one-dimensional photonic crystal (1D PhC) sensor is proposed for high-resolution urine refractive-index detection. The structure consists of alternating TiO₂/MgF₂ layers forming Bragg mirrors with a central urine-filled defect cavity, where a sharp localized resonance is generated inside the photonic band gap. Numerical analysis based on the transfer matrix method shows a stable red shift of the defect mode as the urine refractive index increases from 1.333 to 1.360. The proposed sensor achieves a sensitivity of 388.57 nm/RIU with excellent linearity [Formula: see text], together with an average FWHM of 0.0305 nm, an average Q-factor of [Formula: see text] and an average FOM of [Formula: see text]. A tolerance analysis under ± 2.5% thickness variation confirms that the resonance remains narrow and well defined, demonstrating good fabrication robustness. The results also highlight an important principle in photonic sensing: sensor performance should not be judged by sensitivity alone, but by a balanced combination of sensitivity, linewidth, resonance quality, figure of merit, and tolerance against structural deviations. These findings indicate that the proposed design is a promising candidate for practical urine-based biomedical sensing applications. A comparison with representative previously reported photonic-crystal sensing platforms further confirms the balanced overall performance of the proposed design.

Indexed as

Defect mode resonanceLight–matter interactionOptical biosensorPhotonic crystal sensorRefractive index detectionUrine sensing

Identifiers

PMID42350499
PMCPMC13304118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.